PTC Therapeutics (PTCT) PT Lowered to $46 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $71.97 -0.92%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $46.00 (from $60.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $109 at Wells Fargo
- PTC wins bid for Sangamo's Fabry disease gene therapy in bankruptcy
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
